Julie Bowen

New guidelines reflect a growing interest in behavioral treatments and neuromodulation.

Our Editor in Chief, Heidi Moawad, MD, will be at the Neurology Times booth (No. 2151) on Monday, May 6, from noon to 1:00 PM.

Phase 2 trial results suggest the possibility of a treatment that may regenerate brain cells following TBI.

Obstructive sleep apnea may affect the accumulation of tau in the brain.

Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.

Take this brief quiz to test your knowledge of recent recommendations from the American Headache Society for the prevention and acute management of migraine.

What are the risk factors for serious intracranial injury? When can patients return to normal activity? Answers here.

Are you up-to-date on recent guidelines for the management of agitation, anxiety, apathy, psychosis, and sleep disorders in patients with Huntington disease? Take this brief quiz to find out.